LS
Therapeutic Areas
Genenta Science Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Temferon | Newly Diagnosed Unmethylated Glioblastoma Multiforme (GBM) | Phase 1/2 |
Leadership Team at Genenta Science
PP
Pierluigi Paracchi
Chief Executive Officer
AL
Antonio Lambiase
Chief Medical Officer
GL
Gregory L. Bell
Chief Financial Officer
AA
Alessandro Ambrosi
Chief Business Officer
LN
Luigi Naldini
Co-Founder, Chairman of the Scientific Advisory Board, Director TIGET
BG
Bernhard Gentner
Co-Founder, Head of Research at TIGET
KG
Kleanthis G. Xanthopoulos
Chairman of the Board of Directors
RM
Renato Mazzoncini
Board Member
MB
Michele B. Grosso
Board Member
AA
Alessandro Aiuti
Scientific Advisory Board Member